Background: Neuromyelitis optica spectrum disorder (NMOSD) is an inflammatory central nervous
system disorder with specific pathogenic antibodies (water channel aquaporin-4 immunoglobulin
G, AQP4-IgG). Each relapse in clinical course affects disability. Therefore, this
study aims to prove prognostic factors for first relapse to protect further disability.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of the Neurological SciencesAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
